b-ONE Ortho received FDA 510(k) clearance to market b-ONE™, a cementless total hip system comprising the Juveno™ Femoral Hip and the b-ONE Primary Acetabular System, compatible with b-ONE 12/14 Taper Femoral Heads.
Limited launch will occur in 1H19, followed by full release in 2H19.
This is the first product for the company, which recently raised US $20.0MM in a Series A financing led by Eight Roads Ventures and F-Prime Capital Partners. Proceeds will support product portfolio growth and expansion into ex-U.S. markets.
b-ONE Ortho received FDA 510(k) clearance to market b-ONE™, a cementless total hip system comprising the Juveno™ Femoral Hip and the b-ONE Primary Acetabular System, compatible with b-ONE 12/14 Taper Femoral Heads.
Limited launch will occur in 1H19, followed by full release in 2H19.
This is the first product for the company, which recently...
b-ONE Ortho received FDA 510(k) clearance to market b-ONE™, a cementless total hip system comprising the Juveno™ Femoral Hip and the b-ONE Primary Acetabular System, compatible with b-ONE 12/14 Taper Femoral Heads.
Limited launch will occur in 1H19, followed by full release in 2H19.
This is the first product for the company, which recently raised US $20.0MM in a Series A financing led by Eight Roads Ventures and F-Prime Capital Partners. Proceeds will support product portfolio growth and expansion into ex-U.S. markets.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
